LFchimera protects HeLa cells from invasion by Yersinia spp. in vitro

[1]  Ruifu Yang,et al.  Yersinia pestis YopK Inhibits Bacterial Adhesion to Host Cells by Binding to the Extracellular Matrix Adaptor Protein Matrilin-2 , 2017, Infection and Immunity.

[2]  P. Valenti,et al.  Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation. , 2017, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[3]  S. Verma,et al.  Plague Vaccine Development: Current Research and Future Trends , 2016, Front. Immunol..

[4]  E. Veerman,et al.  Effects of lactoferrin derived peptides on simulants of biological warfare agents , 2016, World journal of microbiology & biotechnology.

[5]  M. Skurnik,et al.  Yersinia adhesins: An arsenal for infection , 2016, Proteomics. Clinical applications.

[6]  S. Atkinson,et al.  Yersinia virulence factors - a sophisticated arsenal for combating host defences , 2016, F1000Research.

[7]  Hope A. Gruszewski,et al.  Differential detection of a surrogate biological threat agent (Bacillus globigii) with a portable surface plasmon resonance biosensor. , 2016, Biosensors & bioelectronics.

[8]  E. Veerman,et al.  Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei , 2016, World Journal of Microbiology and Biotechnology.

[9]  A. Bancerz-Kisiel,et al.  Yersiniosis - a zoonotic foodborne disease of relevance to public health. , 2015, Annals of agricultural and environmental medicine : AAEM.

[10]  C. Urban,et al.  The adhesive protein invasin of Yersinia pseudotuberculosis induces neutrophil extracellular traps via β1 integrins. , 2015, Microbes and infection.

[11]  M. Garza,et al.  Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin , 2014, BioMetals.

[12]  M. Grobusch,et al.  Biological warfare, bioterrorism, and biocrime , 2014, Clinical Microbiology and Infection.

[13]  P. Valenti,et al.  Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases , 2014, BioMetals.

[14]  P. Oyston,et al.  Prophylaxis and therapy of plague , 2013, Expert review of anti-infective therapy.

[15]  E. Veerman,et al.  A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei , 2013, World journal of microbiology & biotechnology.

[16]  N. León-Sicairos,et al.  Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells. , 2012, Biochimie.

[17]  H. Vogel,et al.  Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin. , 2012, Biochimica et biophysica acta.

[18]  BolscherJan,et al.  Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans11This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process. , 2012 .

[19]  León-SicairosNidia,et al.  Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection11This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process. , 2012 .

[20]  Jiyoung Kim,et al.  Human lactoferrin suppresses TNF‐α‐induced intercellular adhesion molecule‐1 expression via competition with NF‐κB in endothelial cells , 2012, FEBS letters.

[21]  Jason A. Rosenzweig,et al.  Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis , 2011, Journal of pathogens.

[22]  F. Bikker,et al.  A comprehensive study on the role of the Yersinia pestis virulence markers in an animal model of pneumonic plague , 2011, Folia Microbiologica.

[23]  M. Garza,et al.  Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli , 2010, BioMetals.

[24]  K. Nazmi,et al.  In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides. , 2009, International journal of antimicrobial agents.

[25]  B. Kan,et al.  O:8 serotype Yersinia enterocolitica strains in China. , 2008, International journal of food microbiology.

[26]  R. Dawson,et al.  Properties and Applications of Antimicrobial Peptides in Biodefense Against Biological Warfare Threat Agents , 2008 .

[27]  P. C. de Visser,et al.  Evaluation of the Antibacterial Spectrum of Drosocin Analogues , 2006, Chemical biology & drug design.

[28]  F. Superti,et al.  Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. , 2004, Journal of medical microbiology.

[29]  F. Ramisse,et al.  Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents. , 2003, The Journal of antimicrobial chemotherapy.

[30]  T. Schwan,et al.  High‐frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut , 2002, Molecular microbiology.

[31]  Scott R. Lillibridge,et al.  Public Health Assessment of Potential Biological Terrorism Agents , 2002, Emerging infectious diseases.

[32]  M. Schaller,et al.  Yersinia enterocolitica invasin protein triggers IL‐8 production in epithelial cells via activation of Rel p65‐p65 homodimers , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  R. Isberg,et al.  A region of the Yersinia pseudotuberculosis invasin protein enhances integrin‐mediated uptake into mammalian cells and promotes self‐association , 1999, The EMBO journal.

[34]  H. Vogel,et al.  Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. , 1998, Biochemistry.

[35]  C. Buchrieser,et al.  Recent emergence of new variants of Yersinia pestis in Madagascar , 1997, Journal of clinical microbiology.

[36]  G. Cornelis,et al.  Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica , 1996, Infection and immunity.

[37]  P. Valenti,et al.  Effect of lactoferricin B, a pepsin-generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pRI203) entry into HeLa cells , 1994, Medical Microbiology and Immunology.

[38]  R. Isberg,et al.  Bacterial internalization mediated by beta 1 chain integrins is determined by ligand affinity and receptor density. , 1993, The EMBO journal.

[39]  E. Veerman,et al.  Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. , 2009, Biochimie.

[40]  D. Heinz,et al.  Adhesins and invasins of pathogenic bacteria: a structural view. , 2004, Microbes and infection.

[41]  C. Buchrieser,et al.  Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. , 2001, Emerging infectious diseases.